Pharmaco - Press Releases

Date	Title	Company
17-Mar-2022	Kite, a Gilead Company, presents long-term CAR T cell therapy data in lymphomas at the 48th EBMT Annual Meeting	Kite, a Gilead Company
17-Mar-2022	National Institute for Health and Care Excellence says ‘yes’ to Darzalex®▼ (daratumumab) for relapsed and refractory multiple myeloma	Janssen Pharmaceutical Companies of Johnson & Johnson
17-Mar-2022	Hansa Biopharma and German payer head association agree on reimbursement price for Idefirix® (imlifidase) as desensitization treatment for highly sensitized kidney transplant patients	Hansa Biopharma
17-Mar-2022	Almac Pharma Services Expands its Unique Ultra-Low Temperature Solutions for Advanced Therapy Medicinal Products	Almac Pharma Services
17-Mar-2022	DnaNudge CEO and co-founder named first ever UK winner of the UNESCO-Equatorial Guinea International Prize for Research in the Life Sciences	DnaNudge
17-Mar-2022	Proenkephalin (penKid) sheds light on the diagnostic blind spots in assessing acute kidney injury in children	SphingoTec GmbH
17-Mar-2022	SDC-1801 on Track to Enter Clinical Development in H2 2022 following Positive Preclinical Data Analysis and Toxicology Report	Sareum Holdings plc
17-Mar-2022	V-Bio Ventures’ Portfolio Company Precirix raises EUR 80m in Series B to advance its pipeline of precision radiopharmaceuticals	V-Bio Ventures
17-Mar-2022	Coriolis Pharma and U-Medico Announce a Strategic Alliance	B3C newswire
17-Mar-2022	Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Reports Final Data from Its Clinical Trial of Novel Nasal Spray, Sentinox, in SARS-CoV-2 Infected Patients	Relief Therapeutics Holding SA
16-Mar-2022	MorphoSys AG Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update	MorphoSys AG
16-Mar-2022	Abivax reports 2021 financial results and operations update	ABIVAX
16-Mar-2022	Toxys Opens US Office and Production Facility to Accelerate Growth	B3C newswire
16-Mar-2022	Biophytis will participate in a key Workshop on Functional Limitations for the elderly	Biophytis
16-Mar-2022	APONTIS PHARMA: START study published in scientific journal - Lower incidence of cardiovascular events with Single Pill therapy	APONTIS PHARMA AG
16-Mar-2022	Invitation to Cosmo’s full-year 2021 results and 2022 outlook webcast presentation on 23 March 2022	Cosmo Pharmaceuticals N.V.
16-Mar-2022	Kuros Biosciences reports results for the full year 2021	Kuros Biosciences AG
16-Mar-2022	SYNLAB AG: SYNLAB achieves record results in 2021 and exceeds all targets set at the IPO	SYNLAB AG
15-Mar-2022	National Comprehensive Cancer Network(R) Updates Designation of Monjuvi(R) (tafasitamab-cxix) to Preferred Regimen in its Clinical Practice Guidelines in Oncology for B-cell Lymphomas	MorphoSys AG
15-Mar-2022	Novasep invests €5.1 million in Le Mans to further expand its production capacity for HPAPIs	Novasep